Key facts
- This page summarizes Greg D. Carmichael's Form 4 filing for Encompass Health Corp (EHC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Apr 2022, 13:47.
Greg D. Carmichael - 18 Apr 2022 Form 4 Insider Report for Encompass Health Corp (EHC)
- Reporting relationship
- Director
- Issuer ticker
- EHC
- Reported as of
- 18 Apr 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Apr 2022, 13:47:25 UTC
- Prior SEC filing
- 18 Feb 2022
- Next SEC filing
- 22 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Patrick Darby, attorney-in-fact for Mr. Carmichael
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Greg D. Carmichael filed Form 4 for Encompass Health Corp (EHC) on 20 Apr 2022.
Change
- Previous filing in this sequence was filed on 18 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EHC
transaction
Encompass Health Common Stock
Award
- Transaction value
- $0
- Shares
- +20
- Change %
- +0.41%
- Price
- $0.000000
- Shares after
- 4,947
- Date
- 18 Apr 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.